clareme-co-founders-Emilia-Theye-and-Celina-Messner-Image-clareme

Empowering Minds: Clare&Me’s Emilia Theye and Celina Messner Raise €3.7 Million to Transform Mental Health with AI

Berlin-based healthtech innovator clare&me has successfully raised €3.7 million in its latest funding round, marking a significant milestone in its mission to enhance mental health support through artificial intelligence. The round was spearheaded by Munich’s YZR Capital, with key contributions from Kodori Ventures, Material Ventures, and existing angel investors, along with early-stage investor Antler. Additionally,…

Read More

Monto’s $9 Million Seed Funding to Accelerate U.S. Expansion and B2B Payment Innovation

Monto, an Israeli fintech innovator specializing in AI-driven solutions for B2B payments, has announced the successful closure of a $9 million seed funding round. The funding, spearheaded by Scale Venture Partners and complemented by investments from Verissimo Ventures, F2 Venture Capital, Firsthand Alliance, and Room40 Ventures, marks a pivotal step as Monto transitions from stealth…

Read More

TERN Raises $7.5M to Challenge GPS Dependence with AI-Driven Navigation System

In a world where everything from ride-hailing to national defense hinges on uninterrupted positioning data, TERN is betting that the future of navigation won’t orbit the Earth. The Austin-based startup has raised $7.5 million in a seed extension round to scale its Independently Derived Positioning System (IDPS™) — a software-based navigation platform that delivers precise…

Read More
ABH Optics Founders

ABH Optics Raises €1M to Pioneer World’s Thinnest Eyeglass Lenses

Copenhagen-based ABH Optics ApS, an innovative spin-off from the Technical University of Denmark (DTU), has successfully raised €1 million in a pre-seed funding round. The investment, led by High-Tech Gründerfonds (HTGF), positions the company to advance its groundbreaking work in developing the world’s thinnest and lightest eyeglass lenses. HTGF’s Senior Investment Manager, Olaf Joeressen, expressed…

Read More

Enginsight Secures €6M to Strengthen Cybersecurity for German SMEs

In a pivotal development for cybersecurity, German startup Enginsight has successfully raised €6 million in funding led by UVC Partners. This round also saw participation from notable investors including Carsten Maschmeyer’s seed+speed fund, bm-t beteiligungsmanagement thüringen GmbH, Talanx AG, Smart Infrastructure Ventures, and Brandenburg VENTURES GmbH. Enginsight is committed to fortifying the cybersecurity landscape for…

Read More

AnchorZero Secures $8M Seed Round to Democratize Billionaire Tax Strategies

AnchorZero, a pioneering fintech firm aimed at democratizing advanced tax strategies previously reserved for the ultrawealthy, has announced a significant milestone today. The company has successfully closed an $8 million seed funding round, led by prominent investors Bain Capital Crypto and Spark Capital, with additional contributions from Ethereal Ventures, Mischief Capital, Pascal Capital, Robot Ventures,…

Read More
Dan Kemp CEO at Shinobi Therapeutics

Shinobi Therapeutics Receives $59M Grant from Japanese Agency for Medical Research and Development

Shinobi Therapeutics, a trailblazer in immune evasive iPS cell therapies, has been awarded up to $59 million in non-dilutive grant funding by the Japanese Agency for Medical Research and Development (AMED). This significant grant will accelerate the development of Shinobi’s pioneering iPS-T cell therapy, aimed at treating GPC3+ solid tumors. Dr. Yasumichi Hitoshi, Chief of…

Read More

Zhiyi Biotech Reports Successful Phase I Results for SK10 in Chemotherapy-induced Diarrhea Treatment

Zhiyi Biotech, a pioneering clinical-stage biotech specializing in live biotherapeutic products (LBPs), has achieved significant milestones with its latest clinical trial results for SK10. The Phase I study, conducted in the United States, has demonstrated promising outcomes in the treatment of chemotherapy-induced diarrhea (CID) using SK10, an innovative heat-killed Bacteroides fragilis product. The randomized, double-blind,…

Read More

eGenesis Secures $191 Million in Series D Funding to Propel Kidney Transplant Innovation

eGenesis, a trailblazer in biotechnology with a focus on developing human-compatible engineered organs, has announced the successful completion of a $191 million Series D financing round. This substantial investment will propel the advancement of eGenesis’s lead product candidate, EGEN-2784, through its first-in-human clinical trials for kidney transplants. Additionally, the funds will facilitate the expansion of…

Read More

PLATMA Secures $2M Pre-Seed Funding for Revolutionary AI-Driven No-Code Platform

PLATMA, an innovative force in the no-code development space, has successfully secured $2 million in pre-seed funding to further advance its AI-powered platform. The Ukrainian-origin startup, which is now valued at $20 million, is setting new standards in the industry by translating natural language directly into functional code. The core of PLATMA’s technology lies in…

Read More